(Reuters) - Moderna Inc's COVID-19 vaccine could start to be used in children and teens in the United States within weeks, its chief executive said in an interview ahead of the Reuters Total Health conference, which will run virtually from Nov. 15-18.
Moderna CEO Staphane Bancel said based on dialogue with the U.S. Food and Drug Administration, he believes his company's COVID-19 vaccine will be authorized for 12- to 17-year-olds in the next few weeks.
Already a subscriber? Log in.
Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!